વર્તમાન કિંમત
લક્ષ્ય કિંમત
વિશ્લેષક ભાવના
6 રેટિંગ્સ: ખરીદો
NervGen Pharma Corp. (NGEN) is an innovative biotechnology company dedicated to addressing critical unmet medical needs in neurodegenerative diseases with its proprietary nerve regeneration technology platform. The compa...|
e.g. Promoter holding
Loading chart...
વિશ્લેષક સર્વસંમતિ EPS અને આવક અનુમાન.
| Metric (B) | FY 2026 | FY 2026 | FY 2026 | FY 2026 | FY 2027 |
|---|---|---|---|---|---|
| $-0.06 | $-0.07 | $-0.10 | $-0.49 | $-0.34 | |
| 0 | 0 | 0 | 0 | 0 | |
| — | -1.5% | +2.8% | +2.0% | +0.8% |
| S.No. | Name | Symbol | Market Cap | P/E | P/B | Profit Margin | Op. Margin | ROE | Rev. Growth |
|---|---|---|---|---|---|---|---|---|---|
| 1. | LLENZ Thera... | LENZ | $129.77M | — | 0.68 | — | -1,211.00% | -72.70% | -72.90% |
| 2. | AAnixa Bios... | ANIX | $91.08M | — | 6.29 | — | — | -73.20% | — |
| 3. | CCaribou Bi... | CRBU | $39.10M | — | 0.51 | — | -1,141.00% | -93.80% | -26.90% |
| 4. | UUnicycive... | UNCY | $97.25M | — | 1.86 | — | — | -101.10% | — |
| 5. | ZZura Bio | ZURA | $119.44M | — | 0.67 | — | — | -63.20% | — |
મિલિયનમાં એકત્રિત આંકડા / સ્ટેન્ડઅલોન જુઓ.
| Quarter (M) | Sep 24 | Dec 24 | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 |
|---|---|---|---|---|---|---|---|---|
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
COGS | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | -0.03 | 0.01 | 0.01 |
Gross Profit | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | 0.03 | -0.01 | -0.01 |
Gross Profit % | - | - | - | - | - | - | - | - |
| 5.33 | 4.72 | 4.18 | 4.74 | 4.42 | 11.73 | 7.64 | 12.51 | |
EBIT | -5.34 | -4.73 | -4.19 | -4.75 | -4.43 | -11.7 | -7.66 | -12.52 |
OPM % | - | - | - | - | - | - | - | - |
Non-Operating Income | 0 | -1.25 | 1.45 | -1.94 | 1.45 | -20 | 5.95 | 0 |
PBT | -3.91 | -5.98 | -2.74 | -6.69 | -2.98 | -31.7 | -1.7 | -29.99 |
Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Rate % | - | - | - | - | - | - | - | - |
Net Income | -3.91 | -5.98 | -2.74 | -6.69 | -2.98 | -31.7 | -1.7 | -29.99 |
NPM % | - | - | - | - | - | - | - | - |
મિલિયનમાં એકત્રિત આંકડા / સ્ટેન્ડઅલોન જુઓ.
| Period (M) | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
COGS | 0 | 0.01 | 0.03 | 0.03 | 0.03 | 0.08 | 0.11 | 0.06 | 0 |
Gross Profit | 0 | -0.01 | -0.03 | -0.03 | -0.03 | -0.08 | -0.11 | -0.06 | 0 |
Gross Profit % | - | - | - | - | - | - | - | - | - |
| 0.01 | 0.98 | 7.58 | 8.76 | 10.09 | 16.9 | 13.3 | 17.27 | 25.08 | |
EBIT | -0.01 | -0.99 | -7.61 | -8.79 | -10.13 | -16.99 | -13.41 | -17.33 | -25.08 |
OPM % | - | - | - | - | - | - | - | - | - |
Non-Operating Income | 0 | 0 | 0 | 0 | 0 | 1.7 | -3.47 | 0.64 | -19.04 |
PBT | -0.01 | -0.99 | -7.53 | -8.78 | -10.06 | -15.29 | -16.89 | -16.68 | -44.12 |
Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Rate % | - | - | - | - | - | - | - | - | - |
Net Income | -0.01 | -0.99 | -7.53 | -8.78 | -10.06 | -15.29 | -16.89 | -16.68 | -44.12 |
NPM % | - | - | - | - | - | - | - | - | - |
મિલિયનમાં એકત્રિત આંકડા / સ્ટેન્ડઅલોન જુઓ.
| Period (M) | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 1.81 | 3.17 | 4.39 | 13.38 | 16.56 | 8.8 | 12 | 22.07 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.08 | 0.01 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0.06 | 1.66 | 0.47 | 0.39 | 0.51 | 0.65 | 1.15 | 0.73 | |
| 0 | 0.4 | 0.39 | 0.37 | 0.38 | 0.54 | 0.54 | 0.32 | 0.4 | |
Total Assets | 0 | 2.27 | 5.22 | 5.24 | 14.15 | 17.61 | 9.99 | 13.54 | 23.21 |
| 0 | 2.82 | 11.79 | 18.01 | 33.52 | 42.35 | 44.46 | 56.36 | 103 | |
| 0 | -0.98 | -7.29 | -13.36 | -20.23 | -32.42 | -45.98 | -54.57 | -99.52 | |
| 0 | 0 | 0 | 0 | 0 | 0.21 | 0.15 | 0.07 | 0.01 | |
| 0 | 0.33 | 0.71 | 0.59 | 0.85 | 9.48 | 14.67 | 11.68 | 19.72 | |
| 0 | 0.1 | 0 | 0 | 0 | -2 | -3.32 | 0 | 0 | |
Total Liabilities | 0 | 2.27 | 5.22 | 5.24 | 14.15 | 17.61 | 9.99 | 13.54 | 23.21 |
મિલિયનમાં એકત્રિત આંકડા / સ્ટેન્ડઅલોન જુઓ.
| Period (M) | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| -0.76 | -6.24 | -4.95 | -6.54 | -13.12 | -8.52 | -11.7 | -19.5 | |
| -0.09 | 0 | -0 | -0.04 | -0.02 | -0.1 | 0.04 | 0.1 | |
| 2.63 | 7.59 | 6.16 | 15.51 | 16.7 | 0.58 | 15.77 | 23.76 | |
Net CFNet Cash Flow | 1.78 | 1.35 | 1.21 | 8.93 | 3.57 | -8.05 | 4.11 | 4.37 |
FCFFree Cash Flow | -0.76 | -6.24 | -4.95 | -6.54 | -13.13 | -8.53 | -11.7 | -19.5 |
Financial ratios and valuation metrics by fiscal year.
| Period | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| - | - | -237.4% | -191.9% | -112.1% | -131.6% | -401.4% | -12149.2% | -1675.1% | |
| - | - | - | - | - | 0.02 | -0.10 | 0.04 | 0.00 | |
| - | 5.68 | 6.77 | 8.21 | 16.16 | 2.27 | 0.83 | 1.12 | 1.16 | |
| - | - | - | - | - | 0.00 | 0.00 | 0.00 | 0.00 | |
Cash Conversion | - | 0.77 | 0.83 | 0.56 | 0.65 | 0.86 | 0.50 | 0.70 | 0.44 |
Payout Ratio | - | - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - | - | |
| - | - | - | - | - | - | - | - | - | |
| - | - | - | - | - | - | - | - | - | |
| - | 3.00 | 3.00 | 3.00 | 4.00 | 2.00 | 2.00 | 4.00 | 3.00 | |
| - | - | - | - | - | - | - | - | - | |
| - | 0.00 | 0.00 | 0.00 | 0.00 | 50.00 | - | 50.00 | 50.00 | |
| - | - | - | - | - | - | - | - | - |
Note: These ratios and scores are calculated using publicly available financial data and may differ from other sources. Users are advised to verify calculations independently using SEC filings or other official sources before making investment decisions.
NANOGEN INC ની માલિકી કોની પાસે છે, SEC ફાઇલિંગ્સ મુજબ
આ કંપની માટે હજુ SEC માલિકી ફાઇલિંગ્સ નથી.
NANOGEN INC ના SEC ફાઇલિંગ્સ અને અર્નિંગ્સ કૉલ ટ્રાન્સક્રિપ્ટ્સ
આ કંપની માટે હજુ SEC ફાઇલિંગ્સ નથી.
What recent news says about NANOGEN INC, scored for sentiment.